Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
AstraZeneca
McKinsey
McKesson
Merck
Medtronic

Last Updated: December 15, 2019

DrugPatentWatch Database Preview

Litigation Details for Bio-Mimetics, Inc. v. Columbia Laboratories, Inc. (D. Mass. )

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Small Molecule Drugs cited in Bio-Mimetics, Inc. v. Columbia Laboratories, Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial and   Start Trial .

Details for Bio-Mimetics, Inc. v. Columbia Laboratories, Inc. (D. Mass. )

Date Filed Document No. Description Snippet Link To Document
2010-03-31 81 first BDS technology patent issued in 1986 as U.S. Patent No. 4,615,697 (the ‘697 patent), entitled “Bioadhesive… U.S. Pat. No. 4,615,697 to Robinson . . . which is incorporated herein.” ‘150 patent, Col. 5, ll. 24…Composition.” The patent application was ultimately issued as U.S. Patent No. 5,474,768 (the ‘768 patent), entitled…Bio-Mimetics], whether patentable or not, which relates to the patents and patent applications set forth…practices Columbia’s U.S. Patent No. 6,248,358 (the ‘358 patent). The ‘150 patent claims a method of targeting External link to document
2010-05-26 94 claims contained in U.S. Patent No. 4,615,697 (‘697 patent). The ‘697 patent expired on October 7, 2003…697 patent. Specifically, Bio-Mimetics notes that because U.S. Patent No. 5,474,768 (‘768 patent), which…extinguished when the last of the foreign patents related to the ‘697 patent expired. After review… whether the patents covering CRINONE and STRIANT were “improvements” on the ‘697 patent, as the Agreement…, that a patent owner cannot by private contract extend the statutory life of a patent. In this External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Colorcon
Harvard Business School
Medtronic
Johnson and Johnson
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.